Sara Cuevas Ocaña Dr George Schlossmacher Professor Neil Perkins Dr Michael Gray
| A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells | 2023 |
|
Dr Jack Leslie Dr Jill Hunter Amy Collins Amelia Rushton Lauren Russell et al. | c-Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis | 2023 |
|
Dr Suzanne Madgwick Dr Saimir Luli Helene Sellier Dr Jacqueline Butterworth Dr Jack Leslie et al. | Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential | 2022 |
|
Dr Jill Hunter Dr Jacqueline Butterworth Helene Sellier Dr Nicola Hannaway Dr Saimir Luli et al. | Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance | 2022 |
|
Dr Jill Hunter Dr Nicola Hannaway Scott Kerridge Dr Saimir Luli Dr Jacqueline Butterworth et al. | Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway | 2022 |
|
Dr Jill Hunter Scott Kerridge Dr Nicola Hannaway Dr Saimir Luli Dr Iglika Ivanova et al. | Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells | 2022 |
|
Dr Jill Hunter Lucy Salmon Dr Caroline Wilson Professor Neil Perkins Dr Owen Davies et al. | Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12 | 2021 |
|
Dr Ling-I Su Emma Corbin Professor Neil Perkins
| Temporal modulation of the NF-B RelA network in response to different types of DNA damage | 2021 |
|
Dr Gema Dura Dr Daniel Peters Dr Helen Waller Dr Adrian Yemm Professor Neil Perkins et al. | A thermally reformable protein polymer | 2020 |
|
Anna Smith Dr Julia Whitehall Carla Bradshaw Dr Fiona Robertson Dr Alasdair Blain et al. | Age-associated mitochondrial DNA mutations cause metabolic remodeling that contributes to accelerated intestinal tumorigenesis | 2020 |
|
Dr Iglika Ivanova Professor Neil Perkins
| Hypoxia induces rapid, STAT3 and ROS dependent, mitochondrial translocation of RelA(p65) and IκBα | 2019 |
|
Majeed Al-Jawdah Dr Iglika Ivanova Dr Helen Waller Professor Neil Perkins Professor Jeremy Lakey et al. | Induction of the immunoprotective coat of Yersinia pestis at body temperature is mediated by the Caf1R transcription factor | 2019 |
|
Dr Katarzyna Szoltysek Dr Simon Cockell Professor Neil Perkins
| RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation | 2018 |
|
Professor Neil Perkins
| More than just an IκB kinase: the IKK complex coordinates mRNA stability and transcription | 2018 |
|
Dr Anna Moles Fernandez Dr Jacqueline Butterworth Dr Jill Hunter Dr Jack Leslie Helene Sellier et al. | A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kB dependent liver regeneration and cancer | 2016 |
|
Dr Jill Hunter Jack Leslie Professor Neil Perkins
| c-Rel and its many roles in cancer: an old story with new twists | 2016 |
|
Dr Tyrell Cartwright Professor Neil Perkins Dr Caroline Wilson
| NFKB1: a suppressor of inflammation, ageing and cancer | 2016 |
|
Dr Jill Hunter Professor Neil Perkins
| The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma | 2016 |
|
Dr Jill Hunter Dr Jacqueline Butterworth Helene Sellier Huw Thomas Dr Christopher Bacon et al. | The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma | 2016 |
|
Dr Anna Moles Fernandez Dr Jacqueline Butterworth Dr Jill Hunter Professor Derek Mann Professor Fiona Oakley et al. | Mutation of Rela THR505 Enhances Liver Regeneration Following Partial Hepatectomy | 2015 |
|
Dr Elaine Willmore Dr Aaron Ions Gardner Dr Susan Tudhope Belinda Murtani Jessica Caffry et al. | Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells | 2015 |
|
Professor Neil Perkins
| The importance of the p50 NF-κB subunit | 2015 |
|
Dr Anna Moles Fernandez Dr Jacqueline Butterworth Dr Jill Hunter Dr Dina Tiniakos Professor Derek Mann et al. | Thr505 RelA phosphorylation controls liver proliferative response and supresses NF-kappa B tumor-promoting activities | 2015 |
|
Dr Adeline Ledoux Dr Jill Hunter Professor Neil Perkins
| Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy | 2014 |
|
Professor Neil Perkins
| Identification of New Mechanisms of Cellular Response to Chemotherapy by Tracking Changes in Post-Translational Modifications by Ubiquitin and Ubiquitin-Like Proteins | 2014 |
|
Dr Adeline Ledoux Professor Neil Perkins
| NF-kB and the cell cycle | 2014 |
|
Professor Neil Perkins
| NF-kappa B is a critical mediator of BRCA1-induced chemoresistance | 2014 |
|
Dr Alessio Iannetti Dr Adeline Ledoux Dr Susan Tudhope Helene Sellier Adam Moore et al. | Regulation of p53 and Rb Links the Alternative NF-kappaB Pathway to EZH2 Expression and Cell Senescence | 2014 |
|
Dr Jill Hunter Dr Jacqueline Butterworth Professor Neil Perkins Professor Melissa Bateson Dr Claire Richardson et al. | Using body temperature, food and water consumption as biomarkers of disease progression in mice with Eμ-myc lymphoma | 2014 |
|
Professor Neil Perkins
| Emerging from NF-kappa B's Shadow, SUMOylated I kappa B alpha Represses Transcription | 2013 |
|
Professor Neil Perkins
| Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence | 2013 |
|
Professor Neil Perkins
| Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21 | 2013 |
|
Dr Lindsay Murphy Dr Saimir Luli Dr Lee Borthwick Dr Steven O'Reilly Professor Neil Perkins et al. | Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response | 2013 |
|
Dr Adeline Ledoux Helene Sellier Dr Alessio Iannetti Professor Neil Perkins
| NF kappa B regulates expression of Polo-like kinase 4 | 2013 |
|
Professor Fiona Oakley Professor Neil Perkins
| BAG-1 interacts with the p50-p50 homodimeric NF-kappa B complex: implications for colorectal carcinogenesis | 2012 |
|
Professor Neil Perkins
| Cysteine 38 Holds the Key to NF-kappa B Activation | 2012 |
|
Dr Renee Johnson Professor Neil Perkins
| Nuclear factor-kappa B, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect | 2012 |
|
Professor Neil Perkins
| The diverse and complex roles of NF-kappa B subunits in cancer. | 2012 |
|
Dr Renee Johnson Professor Neil Perkins
| p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB | 2011 |
|
Professor Neil Perkins Dr Renee Johnson
| The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration | 2011 |
|
Professor Neil Perkins
| p53-dependent repression of polo-like kinase-1 (PLK1) | 2010 |
|
Professor Neil Perkins
| Regulation of cyclin D1 gene expression | 2010 |
|
Professor Neil Perkins
| Thr(435) phosphorylation regulates RelA (p65) NF-kappa B subunit transactivation | 2010 |
|
Professor Neil Perkins
| [abstract] Regulation of cancer cell proliferation and survival by NF-kappa B | 2009 |
|
Professor Neil Perkins
| Getting away from it all in Capri: the 2008 EMBO workshop on NF-kappa B | 2009 |
|
Professor Neil Perkins
| A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300 | 2008 |
|
Professor Neil Perkins
| IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis | 2008 |
|
Professor Neil Perkins
| Regulation of cyclin D1 RNA stability by SNIP1 | 2008 |
|
Professor Neil Perkins
| Regulation of the ReIA (p65) transactivation domain | 2008 |
|
Professor Neil Perkins
| Integrating cell-signalling pathways with NF-kappaB and IKK function | 2007 |
|
Professor Neil Perkins
| p53 and NF-κB crosstalk: IKKα tips the balance | 2007 |
|
Professor Neil Perkins
| Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets | 2007 |
|
Professor Neil Perkins
| Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1 | 2007 |
|
Professor Neil Perkins
| Transcriptional profiling of the LPS induced NF-κB response in macrophages | 2007 |
|
Professor Neil Perkins
| Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation | 2006 |
|
Professor Neil Perkins
| Differential regulation of NF-κB activation and function by topoisomerase II inhibitors | 2006 |
|
Professor Neil Perkins
| Good cop, bad cop: the different faces of NF-kappaB | 2006 |
|
Professor Neil Perkins
| Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway | 2006 |
|
Professor Neil Perkins
| Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit | 2006 |
|
Professor Neil Perkins
| SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes | 2006 |
|
Professor Neil Perkins
| ARF the integrator: linking NF-kappaB, p53 and checkpoint kinases | 2005 |
|
Professor Neil Perkins
| Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism | 2005 |
|
Professor Neil Perkins
| Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases | 2005 |
|
Professor Neil Perkins
| p21(WAF1/CIP1) regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of Cyclin/CDK binding | 2005 |
|
Professor Neil Perkins
| Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor | 2005 |
|
Professor Neil Perkins
| Regulation of NF-kappaB function | 2005 |
|
Professor Neil Perkins
| SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1 | 2005 |
|
Professor Neil Perkins
| The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor | 2005 |
|